Periorbital edema secondary to imatinib mesylate
Collin M McClelland, George J Harocopos, Philip L CusterSchool of Medicine, Washington University, St. Louis, MO, USAAbstract: Imatinib mesylate (Gleevec®) is a well-established pharmacologic treatment for all phases of chronic myeloid leukemia and for advanced gastrointestinal stromal t...
Saved in:
Main Authors: | , , |
---|---|
Format: | article |
Language: | EN |
Published: |
Dove Medical Press
2010
|
Subjects: | |
Online Access: | https://doaj.org/article/b24ecbe6ffba41f2b443f72352e293e2 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|